Henlius Biotech Gets European Commission's Nod for Hetronifly

MT Newswires Live05-11

Shanghai Henlius Biotech (HKG:2696), Shanghai Fosun Pharmaceutical's (SHA:600196, HKG:2196) unit, received approval from the European Commission for its serplulimab injection, which has the trade name Hetronifly, according to a Hong Kong bourse filing on Sunday.

Henlius' shares slipped 1% during Monday's morning trade.

The drug is used in combination with fluoropyrimidineand platinum-based chemotherapy for the treatment of adult patients with unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma.

The drug is also used in combination with carboplatin and pemetrexed indicated for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung carcinoma.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2634475343?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-11 10:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2634475343","market":"us","top_or_hot":-1,"title":"Henlius Biotech Gets European Commission's Nod for Hetronifly","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SGBCF\">Shanghai Henlius Biotech</a> (HKG:2696), <a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun</a> Pharmaceutical's (SHA:600196, HKG:2196) unit, received approval from the European Commission for its serplulimab injection, which has the trade name Hetronifly, according to a Hong Kong bourse filing on Sunday.</p><p>Henlius' shares slipped 1% during Monday's morning trade.</p><p>The drug is used in combination with fluoropyrimidineand platinum-based chemotherapy for the treatment of adult patients with unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma.</p><p>The drug is also used in combination with carboplatin and pemetrexed indicated for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung carcinoma.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Henlius Biotech Gets European Commission's Nod for Hetronifly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHenlius Biotech Gets European Commission's Nod for Hetronifly\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-11 10:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SGBCF\">Shanghai Henlius Biotech</a> (HKG:2696), <a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun</a> Pharmaceutical's (SHA:600196, HKG:2196) unit, received approval from the European Commission for its serplulimab injection, which has the trade name Hetronifly, according to a Hong Kong bourse filing on Sunday.</p><p>Henlius' shares slipped 1% during Monday's morning trade.</p><p>The drug is used in combination with fluoropyrimidineand platinum-based chemotherapy for the treatment of adult patients with unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma.</p><p>The drug is also used in combination with carboplatin and pemetrexed indicated for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung carcinoma.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1593","symbol_name":"医美概念股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2634475343","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2634475343","pubTimestamp":1778467398,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Henlius Biotech (HKG:2696), Shanghai Fosun Pharmaceutical's (SHA:600196, HKG:2196) unit, received approval from the European Commission for its serplulimab injection, which has the trade name","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","BK1593":"医美概念股","BK0175":"白马股","BK0060":"抗癌","BK4581":"高盛持仓","BK1161":"生物科技","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","BK1515":"抗疫概念","BK4585":"ETF&股票定投概念","BK0196":"行业龙头","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","BK0239":"医药制造","BK0096":"民营医院","02696":"复宏汉霖","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","EPV":"ProShares UltraShort MSCI Europe","BK0183":"MSCI概念","BK4588":"碎股","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","BK0188":"融资融券","BK0012":"证金概念","BK0187":"一线龙头","BK0028":"国家队","XBI":"SPDR S&P Biotech ETF","BK1191":"制药","02196":"复星医药"},"translate_title":"复宏汉霖生物获得欧盟委员会批准Hetronifly","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":0.9,"EPV":1.5,"02696":1,"XBI":1.5,"02196":0.9},"content_text":"Shanghai Henlius Biotech (HKG:2696), Shanghai Fosun Pharmaceutical's (SHA:600196, HKG:2196) unit, received approval from the European Commission for its serplulimab injection, which has the trade name Hetronifly, according to a Hong Kong bourse filing on Sunday.Henlius' shares slipped 1% during Monday's morning trade.The drug is used in combination with fluoropyrimidineand platinum-based chemotherapy for the treatment of adult patients with unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma.The drug is also used in combination with carboplatin and pemetrexed indicated for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung carcinoma.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2634475343","isCrawlerRequest":true}